<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">269</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>COMPARATIVE ANALYSIS OF SENSITIVITY AND SPECIFICITY OF CARDIAC SPECIFIC TROPONIN I AND CK-MB FOR DIAGNOSIS OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Sandipkumar R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Hariom</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vanani</surname><given-names>Bhavika</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>12</day><month>05</month><year>2016</year></pub-date><volume/><issue/><fpage>21</fpage><lpage>25</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Background: Study is designed to see correlation of cardiac specific Troponin I and Creatine Kinase-MB level to diagnose ST segment elevation myocardial infarction. Aim and Objectives: To access the diagnostic importance of cardiac specific Troponin I over Creatine Kinase-MB in patient of ST-segment elevation myocardial infarction. Materials and Methods: A comparative study was carried out in 100 patients, having ST segment elevation myocardial infarction. A group of 100 normal healthy individuals, age and sex matched from the same population served as controls. Troponin I and Creatine Kinase-MB levels were estimated in both the groups. Results: Results of present study shows that cardiac specific Troponin I and CK-MB levels were significantly higher in STEMI patients compared to healthy subjects with __ampersandsignlsquo;p__ampersandsignrsquo; value of __ampersandsignlt;0.0001. Pearson__ampersandsignrsquo;s correlation test show positive correlation between Troponin I and CK-MB in STEMI patients. 17% of STEMI patients had normal CK-MB levels, but there Troponin I levels were elevated significantly. Conclusion: Troponin I level is more specific for confirming the diagnosis of acute myocardial infarction where CK-MB fails to do so.&#13;
</p></abstract><kwd-group><kwd>Troponin I</kwd><kwd> ST-segment elevation myocardial infarction (STEMI)</kwd><kwd> Creatine Kinase – MB (CK-MB)</kwd></kwd-group></article-meta></front></article>
